Furthermore, signature 28, often found in cancers with mutations in POLE (Alexandrov et al., 2018), continued to be generated in all of these cell lines but not in the examined stomach cancer cell line (AGS) (Figure 3; Table S3). This evidence concerns the gene POLE and gastric neoplasm.